FindTrial
Sign In

A clinical trial to study the benefits of a drug Tranexamic acid in patients undergoing keyhole surgery for renal stones called percutaneous nephrolithotomy.

A Prospective Randomized Controlled Trial â?? Comparing the efficacy of Tranexamic acid in reducing the blood loss during PCNL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/01/011374
Enrollment
200
Registered
2018-01-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients undergoing surgery for renal stones â?? PCNL.

Interventions

Intervention1: Tranexamic acid: A clinical trial to study the benefits of a drug Tranexamic acid in patients undergoing surgery for renal stones â?? PCNL. Percutaneous Nephrolilthotomy (PCNL) is the

Sponsors

Meenakshi Mission Hospital and Research center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients undergoing PCNL surgery at MMHRC 2. > 18 years of age

Exclusion criteria

Exclusion criteria: 1. Pregnant subjects 2. Infection stones 3. Coagulopathic conditions 4. Chronic kidney disease

Design outcomes

Primary

MeasureTime frame
Primary outcomes 1. Mean haemoglobin drop on second post-operative day 2. Blood transfusion rate before dischargeTimepoint: 1. Second post-operative day 2. At discharge—

Secondary

MeasureTime frame
Stone size Operation time Stone clearance rate Duration of hospitalisation Side effects of tranexamic acid Timepoint: 1 week—

Countries

India

Contacts

Public ContactDr Paul Vincent D

Meenakshi Mission Hospital & Research Centre

pauldevincent@rediffmail.com9626733363

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026